Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation

International Journal of Radiation Oncology, Biology, Physics
Mathilda L BongersCornelia A Uyl-de Groot

Abstract

To evaluate long-term health effects, costs, and cost-effectiveness of positron emission tomography (PET)-based isotoxic accelerated radiation therapy treatment (PET-ART) compared with conventional fixed-dose CT-based radiation therapy treatment (CRT) in non-small cell lung cancer (NSCLC). Our analysis uses a validated decision model, based on data of 200 NSCLC patients with inoperable stage I-IIIB. Clinical outcomes, resource use, costs, and utilities were obtained from the Maastro Clinic and the literature. Primary model outcomes were the difference in life-years (LYs), quality-adjusted life-years (QALYs), costs, and the incremental cost-effectiveness and cost/utility ratio (ICER and ICUR) of PET-ART versus CRT. Model outcomes were obtained from averaging the predictions for 50,000 simulated patients. A probabilistic sensitivity analysis and scenario analyses were carried out. The average incremental costs per patient of PET-ART were €569 (95% confidence interval [CI] €-5327-€6936) for 0.42 incremental LYs (95% CI 0.19-0.61) and 0.33 QALYs gained (95% CI 0.13-0.49). The base-case scenario resulted in an ICER of €1360 per LY gained and an ICUR of €1744 per QALY gained. The probabilistic analysis gave a 36% probability that PET...Continue Reading

References

Jun 28, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L J VanuytselG J Kutcher
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Dirk De RuysscherPhilippe Lambin
Jun 20, 2006·Social Science & Medicine·Johan J PolderHans van Oers
Sep 23, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Marjolein PompenPieter Postmus
Dec 20, 2008·International Journal of Radiation Oncology, Biology, Physics·Cary Dehing-OberijePhilippe Lambin
Jan 17, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Cary Dehing-OberijePhilippe Lambin
Jan 29, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Andrea PeetersPhilippe Lambin
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angela van BaardwijkDirk De Ruysscher
May 8, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Julie Sturza
Jul 6, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M W J M WoutersF M N H Schramel
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk De RuysscherSuresh Senan
Nov 19, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Cary Dehing-OberijePhilippe Lambin
Sep 17, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Dirk De RuysscherMichael Macmanus
Jul 4, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Audrey MauguenJean-Pierre Pignon
Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Bram L T RamaekersJanneke P C Grutters

❮ Previous
Next ❯

Citations

Nov 22, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·N van der LindenC A Uyl-de Groot
Mar 18, 2016·Cancer Treatment Reviews·Cyrus ChargariEric Deutsch
Mar 4, 2015·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Mathilda L BongersV M H Coupé
Nov 11, 2017·International Journal of Technology Assessment in Health Care·Mathilda L BongersVeerle M H Coupé

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.